Send feedback

CAPS2 p.Ser52=

c.156C>T · rs11180461 · VCV778643

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
low-frequency (popmax 1.66%, afr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.6GERP 0.53, phastCons 1
Overall
CADD8.447PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.66% African / African-American · 1,208/72,942 alleles
Filtering AF 1.58% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.55%
Overall 0.0957% 1,477/1,543,944 alleles · low-frequency
Ancestry group Frequency 1 in
African / African-Americangrpmax 1.66% 60
Admixed American 0.165% 605
Remaining individualsnot grpmax-eligible 0.142% 702
East Asian 0.135% 740
Middle Eastern 0.0906% 1,103
South Asian 0.00483% 20,725
European (non-Finnish) 0.00324% 30,903

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CAPS2
Protein
p.Ser52=
Coding
c.156C>T
MANE Select
NM_017954 · reported on NM_001355024
dbSNP
rs11180461
Type
single nucleotide variant
Location
chr12:75323198 (GRCh38)
Structure
AlphaFold pLDDT 79.91
Residue 52
the 'disordered' region
Full CAPS2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/caps2-p-ser52 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown